News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,387 Results
Type
Article (41617)
Company Profile (292)
Press Release (688462)
Multimedia
Podcasts (96)
Webinars (20)
Section
Business (205712)
Career Advice (2041)
Deals (35686)
Drug Delivery (128)
Drug Development (81675)
Employer Resources (173)
FDA (16511)
Job Trends (15026)
News (347977)
Policy (32859)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2610)
Accelerated approval (43)
Adcomms (25)
Allergies (164)
Alliances (49924)
ALS (197)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (399)
Approvals (16846)
Artificial intelligence (613)
Autoimmune disease (236)
Automation (51)
Bankruptcy (365)
Best Places to Work (11658)
BIOSECURE Act (21)
Biosimilars (209)
Biotechnology (190)
Bladder cancer (180)
Brain cancer (66)
Breast cancer (696)
Cancer (5455)
Cardiovascular disease (452)
Career advice (1730)
Career pathing (41)
CAR-T (308)
CDC (55)
Celiac Disease (2)
Cell therapy (818)
Cervical cancer (43)
Clinical research (70495)
Collaboration (1983)
Company closure (4)
Compensation (1305)
Complete response letters (74)
COVID-19 (2746)
CRISPR (101)
C-suite (1033)
Cystic fibrosis (151)
Data (7222)
Decentralized trials (3)
Denatured (31)
Depression (156)
Dermatology (69)
Diabetes (554)
Diagnostics (6880)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (307)
Drug pricing (198)
Drug shortages (31)
Duchenne muscular dystrophy (268)
Earnings (91304)
Editorial (61)
Employer branding (21)
Employer resources (152)
Events (119139)
Executive appointments (1055)
FDA (20019)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1664)
Gene editing (218)
Generative AI (54)
Gene therapy (663)
GLP-1 (1030)
Government (4724)
Grass and pollen (6)
Guidances (400)
Healthcare (18979)
HIV (76)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (87)
Indications (163)
Infectious disease (3077)
Inflammatory bowel disease (206)
Inflation Reduction Act (16)
Influenza (133)
Intellectual property (277)
Interviews (316)
IPO (16686)
IRA (52)
Job creations (3681)
Job search strategy (1442)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (566)
Leadership (35)
Legal (7987)
Liver cancer (98)
Longevity (29)
Lung cancer (730)
Lymphoma (411)
Machine learning (54)
Management (59)
Manufacturing (960)
MASH (178)
Medical device (13887)
Medtech (13969)
Mergers & acquisitions (20177)
Metabolic disorders (1432)
mRNA (180)
Multiple sclerosis (177)
NASH (17)
Neurodegenerative disease (388)
Neuropsychiatric disorders (98)
Neuroscience (3186)
Neurotech (1)
NextGen: Class of 2026 (6558)
Non-profit (4536)
Now hiring (74)
Obesity (676)
Opinion (283)
Ovarian cancer (197)
Pain (236)
Pancreatic cancer (267)
Parkinson's disease (346)
Partnered (35)
Patents (563)
Patient recruitment (619)
Peanut (60)
People (59701)
Pharmaceutical (61)
Pharmacy benefit managers (32)
Phase 1 (21986)
Phase 2 (31043)
Phase 3 (23099)
Pipeline (7445)
Policy (309)
Postmarket research (2567)
Preclinical (9340)
Press Release (64)
Prostate cancer (281)
Psychedelics (49)
Radiopharmaceuticals (311)
Rare diseases (1010)
Real estate (6007)
Recruiting (70)
Regulatory (25153)
Reports (54)
Research institute (2416)
Resumes & cover letters (354)
Rett syndrome (33)
RNA editing (21)
RSV (87)
Schizophrenia (167)
Series A (279)
Series B (207)
Service/supplier (13)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3683)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (88)
The Weekly (63)
Vaccines (1070)
Venture capital (101)
Weight loss (434)
Women's health (114)
Worklife (20)
Date
Today (155)
Last 7 days (605)
Last 30 days (2636)
Last 365 days (30310)
2026 (9109)
2025 (30328)
2024 (35323)
2023 (40178)
2022 (51288)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32221)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (742)
Alabama (91)
Alaska (7)
Arizona (335)
Arkansas (14)
Asia (39736)
Australia (6520)
California (12516)
Canada (3584)
China (1258)
Colorado (537)
Connecticut (540)
Delaware (375)
Europe (85906)
Florida (1882)
Georgia (402)
Hawaii (3)
Idaho (63)
Illinois (994)
India (85)
Indiana (577)
Iowa (22)
Japan (503)
Kansas (130)
Kentucky (46)
Louisiana (38)
Maine (75)
Maryland (1505)
Massachusetts (8936)
Michigan (349)
Minnesota (687)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (84)
New Jersey (3324)
New Mexico (28)
New York (3290)
North Carolina (1582)
North Dakota (8)
Northern California (6206)
Ohio (375)
Oklahoma (23)
Oregon (43)
Pennsylvania (2527)
Puerto Rico (28)
Rhode Island (50)
South America (1115)
South Carolina (82)
South Dakota (2)
Southern California (4922)
Tennessee (202)
Texas (1981)
United States (44310)
Utah (376)
Vermont (1)
Virginia (297)
Washington D.C. (81)
Washington State (1009)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
730,387 Results for "alamar biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
March 17, 2026
·
4 min read
Press Releases
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
January 12, 2026
·
3 min read
Press Releases
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
January 13, 2026
·
2 min read
Press Releases
Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
October 16, 2025
·
2 min read
Press Releases
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research
October 9, 2025
·
3 min read
Press Releases
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer’s Association International Conference (AAIC)
July 29, 2025
·
3 min read
Press Releases
Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease
May 28, 2025
·
2 min read
Press Releases
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
July 30, 2025
·
3 min read
Press Releases
Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120
March 25, 2025
·
2 min read
Business
Alamar Biosciences and Biomarkers of Aging Consortium Join Forces to Revolutionize Longevity Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium announced the launch of the next phase of the Biomarkers of Aging Challenge Series.
June 27, 2024
·
3 min read
1 of 73,039
Next
